קלרידקס

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

CLARITHROMYCIN

Pieejams no:

DEXCEL LTD, ISRAEL

ATĶ kods:

J01FA09

Zāļu forma:

קפליות

Kompozīcija:

CLARITHROMYCIN 250 MG

Ievadīšanas:

פומי

Receptes veids:

מרשם נדרש

Ražojis:

DEXCEL LTD, ISRAEL

Ārstniecības grupa:

CLARITHROMYCIN

Ārstniecības joma:

CLARITHROMYCIN

Ārstēšanas norādes:

Klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include: Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. Upper respiratory tract infections, for example, sinusitis and pharyngitis. Klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. Klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. Klaridex is also indicated in combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer. Treatment of Mycobacterium Avium Complex infection in AIDS patients.

Autorizācija datums:

2014-05-31